Milrila Injection 10mg (ミルリーラ注射液10mg)

Nchi: Japani

Lugha: Kiingereza

Chanzo: すりの適正使用協議会 RAD-AR Council, Japan

Nunua Sasa

Taarifa za kipeperushi Taarifa za kipeperushi (PIL)
01-07-2021

Viambatanisho vya kazi:

Milrinone

Inapatikana kutoka:

Nichi-iko Pharmaceutical Co.,Ltd

INN (Jina la Kimataifa):

Milrinone

Dawa fomu:

injection

Taarifa za kipeperushi

                                Drug Information Sheet("Kusuri-no-Shiori")
Injection
Published: 07/2021
The information on this sheet is based on approvals granted by the
Japanese regulatory authority. Approval
details may vary by country. Medicines have adverse reactions (risks)
as well as efficacies (benefits). It is
important to minimize adverse reactions and maximize efficacy. To
obtain a better therapeutic response,
patients should understand their medication and cooperate with the
treatment.
BRAND NAME:
MILRILA INJECTION 10MG
ACTIVE INGREDIENT:
Milrinone
DOSAGE FORM:
injection
IMPRINT OR PRINT ON WRAPPING:
EFFECTS OF THIS MEDICINE
This medicine enhances cardiac contractility and dilates blood
vessels.
It is usually used to treat acute heart failure.
THE FOLLOWING PATIENTS MAY NEED TO BE CAREFUL WHEN USING THIS
MEDICINE.BE SURE TO TELL YOUR DOCTOR
AND PHARMACIST.
・If you have previously experienced any allergic reactions (itch,
rash, etc.) to any medicines
or foods.
If you have hypertrophic obstructive cardiomyopathy.
・If you are pregnant or breastfeeding.
・If you are taking any other medicinal products. (Some medicines may
interact to enhance or
diminish medicinal effects. Beware of over-the-counter medicines and
dietary supplements
as well as other prescription medicines.)
DOSING SCHEDULE (HOW TO TAKE THIS MEDICINE)
・
Your dosing schedule prescribed by your doctor is((         
           
to be written by a healthcare
professional
))
・In general, inject intravenously. Subsequently, inject by
intravenous infusion.
・The treatment period with this medicine depends on your response to
the treatment.
PRECAUTIONS WHILE TAKING THIS MEDICINE
POSSIBLE ADVERSE REACTIONS TO THIS MEDICINE
The most commonly reported adverse reactions include tachycardia,
liver dysfunction and
vomiting. If any of these symptoms occur, consult with your doctor or
pharmacist.
THE SYMPTOMS DESCRIBED BELOW ARE RARELY SEEN AS INITIAL SYMPTOMS OF
THE ADVERSE REACTIONS INDICATED
IN BRACKETS. IF ANY OF THESE SYMPTOMS OCCUR, STOP TAKING THIS 
                                
                                Soma hati kamili
                                
                            

Tafuta arifu zinazohusiana na bidhaa hii